Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,96119,980 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Determining the role of LSD1 in multiple myeloma through a multi-omics approach at single cell resolution
NATIONAL CANCER INSTITUTE Harvard University United States 2021 – 2026

PROJECT SUMMARY / ABSTRACT Multiple myeloma (MM) kills nearly 13,000 people annually in the United States1.MM is preceded by a less life- threating blood condition, which is simila...

$460.4K
USD
Completed TRAINING, INDIVIDUAL
Thermodynamic and Allosteric Basis of Paradoxical Activation in V600E Mutant BRAF Cancers
NATIONAL CANCER INSTITUTE University of Minnesota United States 2021 – 2024

PROJECT SUMMARY The activating V600E mutation in the protein kinase BRAF is a well-established driver of human cancer. The effectiveness of current BRAF inhibitors developed to tar...

$325.1K
USD
Completed NON-SBIR/STTR RPGS
The Impact of Gut Microbiota on the Sex Difference in Bladder Cancer
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2021 – 2023

Men are 3-5 times more likely than women to develop and die from bladder cancer (BCa) but the underlying mechanisms of these gender disparities in BCa are poorly understood. This i...

$1.91M
USD
Completed OTHER RESEARCH-RELATED
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2022

Abstract Emerging evidence suggests that childhood cancer survivors treated without central nervous system (CNS) directed therapies are at significant risk for neurocognitive impai...

$1.23M
USD
Completed OTHER RESEARCH-RELATED
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2022

Abstract Emerging evidence suggests that childhood cancer survivors treated without central nervous system (CNS) directed therapies are at significant risk for neurocognitive impai...

$1.23M
USD
Completed NON-SBIR/STTR RPGS
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors
NATIONAL CANCER INSTITUTE University of Rochester United States 2021 – 2025

Abstract Emerging evidence suggests that childhood cancer survivors treated without central nervous system (CNS) directed therapies are at significant risk for neurocognitive impai...

$2.49M
USD
Completed NON-SBIR/STTR RPGS
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors
NATIONAL CANCER INSTITUTE University of Rochester United States 2021 – 2025

Abstract Emerging evidence suggests that childhood cancer survivors treated without central nervous system (CNS) directed therapies are at significant risk for neurocognitive impai...

$1.57M
USD
Completed NON-SBIR/STTR RPGS
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors
NATIONAL CANCER INSTITUTE University of Rochester United States 2021 – 2025

Abstract Emerging evidence suggests that childhood cancer survivors treated without central nervous system (CNS) directed therapies are at significant risk for neurocognitive impai...

$2.49M
USD
Completed NON-SBIR/STTR RPGS
Tissue Damage-Driven Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2025

Squamous cell carcinoma (SCC) is responsible for ~10% of total cancer mortality worldwide.SCC prognosis is context-dependent and does not seem to be determined by driver gene somat...

$3.57M
USD
Completed NON-SBIR/STTR RPGS
Targeting Atg5 in platinum-resistant ovarian cancer
NATIONAL CANCER INSTITUTE Wayne State University United States 2021 – 2022

Abstract Ovarian cancer is the fifth leading cause of cancer-related death in the United States.The standard first line chemotherapy to treat this deadly disease includes platinum...

$1.8M
USD
Completed OTHER RESEARCH-RELATED
Unpacking the Multi-level Drivers of Cardiotoxicity Disparities in Breast Cancer Survivors
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2021 – 2022

Abstract The improvement in breast cancer survival is partially due to improvements in treatments. However, these treatments are not without mild to life-threatening side effects.F...

$1.11M
USD
Completed NON-SBIR/STTR RPGS
Redefining hemophagocytic lymphohistiocytosis in hematologic malignancies
NATIONAL CANCER INSTITUTE Cincinnati Childrens Hosp Med Ctr United States 2021 – 2022

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening inflammatory syndrome that is increasingly recognized in patients with malignancies (M-HLH).However, nearly early eve...

$1.86M
USD
Completed NON-SBIR/STTR RPGS
Cerebrospinal fluid derived circulating tumor DNA as a clinically relevant biomarker in medulloblastoma
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2022

PROJECT SUMMARY Medulloblastoma (MB) is among the most common malignant brain tumors in children.Despite advances in multi-modal patient care and understanding of tumor biology, on...

$2.1M
USD
Completed NON-SBIR/STTR RPGS
Angiogenic biomarker discovery to direct bevacizumab therapy in cervical cancer - Blood-based Angiome Profiling: An ancillary analysis of GOG-0240
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2022

Project Summary The anti-angiogenic agent bevacizumab (BEV) is one of the most effective forms of biologic therapy developed thus far for cervical cancer (CC). However, response is...

$2.68M
USD
Completed NON-SBIR/STTR RPGS
Investigating Mechanisms of Hyperprogression on Anti-PD-1 Immunotherapy
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2022

Abstract The number of cancer patients being treated with checkpoint blockade immunotherapy (CBI) targeting the PD- 1/PD-L1 pathway is increasing dramatically.Recently a novel and...

$1.84M
USD
Completed NON-SBIR/STTR RPGS
Genetic analysis of lung cancer susceptibility
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2022

Abstract Although tobacco exposure is the major determinant of lung cancer, only about 15% of smokers develop lung cancer.In this study, we seek to identify genetic effects that in...

$800K
USD
Completed NON-SBIR/STTR RPGS
Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors and lung cancer prognosis
NATIONAL CANCER INSTITUTE Trustees of Indiana University United States 2021 – 2022

Project Abstract Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a relatively new class of antidiabetic drugs. The use of this class of drugs is on the rise.In addition to it...

$792.5K
USD
Completed OTHER RESEARCH-RELATED
Improving CAR T cell therapy for brain tumors using immune competent models
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT The overall objective of this study is to engineer a potent CAR T cell therapy for high grade glioma (HGG), a subgroup of brain tumors for which outcomes r...

$1.25M
USD
Completed OTHER RESEARCH-RELATED
Methods for Mendelian randomization and mediation analysis using integrative genetic and genomic data for breast cancer
NATIONAL CANCER INSTITUTE Harvard School of Public Health United States 2021 – 2022

Project summary Haoyu Zhang, PhD is a statistician whose ultimate career goal is incorporating advanced causal inference techniques into genetics and biological research in order t...

$1M
USD
Completed OTHER RESEARCH-RELATED
Identifying new drivers of ovarian cancer from the non-coding genome by converging germline risk variants and somatic mutations
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT The goal of the proposed research training program is to provide tailored additional training to facilitate successful career development throughout the co...

$1.73M
USD